These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16721452)

  • 1. [Flu vaccine in children: state of the art].
    Vega-Briceño LE; Abarca V K; Sánchez D I
    Rev Chilena Infectol; 2006 Jun; 23(2):164-9. PubMed ID: 16721452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England.
    Thorrington D; van Leeuwen E; Ramsay M; Pebody R; Baguelin M
    BMC Med; 2017 Sep; 15(1):166. PubMed ID: 28882149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
    Thommes EW; Ismaila A; Chit A; Meier G; Bauch CT
    BMC Infect Dis; 2015 Oct; 15():465. PubMed ID: 26503131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated versus inactivated influenza vaccine in infants and young children.
    Belshe RB; Edwards KM; Vesikari T; Black SV; Walker RE; Hultquist M; Kemble G; Connor EM;
    N Engl J Med; 2007 Feb; 356(7):685-96. PubMed ID: 17301299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization against viral respiratory disease: a review.
    Greenberg HB; Piedra PA
    Pediatr Infect Dis J; 2004 Nov; 23(11 Suppl):S254-61. PubMed ID: 15577581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influenza: immunization to new age groups].
    Abarca V K
    Rev Chilena Infectol; 2007 Jun; 24(3):227-30. PubMed ID: 17554443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium.
    Gerlier L; Lamotte M; Dos Santos Mendes S; Damm O; Schwehm M; Eichner M
    Paediatr Drugs; 2016 Aug; 18(4):303-18. PubMed ID: 27272706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age.
    Allsup S; Gosney M; Haycox A; Regan M
    Health Technol Assess; 2003; 7(24):iii-x, 1-65. PubMed ID: 14499051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza: A Global Perspective.
    Rotrosen ET; Neuzil KM
    Pediatr Clin North Am; 2017 Aug; 64(4):911-936. PubMed ID: 28734518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an immunization program on seasonal influenza hospitalizations in Mexican children.
    Aranda-Romo S; Comas-García A; García-Sepúlveda CA; Hernández-Salinas AE; Piña-Ramírez M; Noyola DE
    Vaccine; 2010 Mar; 28(13):2550-5. PubMed ID: 20117263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
    Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of influenza hospitalization at a tertiary care children's hospital and its impact on the cost-benefit analysis of the recommendation for universal influenza immunization in children age 6 to 23 months.
    Hall JL; Katz BZ
    J Pediatr; 2005 Dec; 147(6):807-11. PubMed ID: 16356436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated influenza vaccine for children.
    Drug Ther Bull; 2017 Oct; 55(10):114-117. PubMed ID: 29021248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
    Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
    Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should all Australian children be vaccinated against influenza?
    Isaacs D
    Med J Aust; 2005 Jun; 182(11):553-4. PubMed ID: 15938679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Bridges CB; Harper SA; Fukuda K; Uyeki TM; Cox NJ; Singleton JA;
    MMWR Recomm Rep; 2003 Apr; 52(RR-8):1-34; quiz CE1-4. PubMed ID: 12755288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.